198
Publications
31.7K
Citations
68
H-Index
1998
Active since
Mario Mandalà is an author at Ospedale Papa Giovanni XXIII specializing in medicine, oncology, and radiation oncology.
Top concepts
MedicineOncologyRadiation OncologyCancer TherapyCancer ResearchMolecular OncologyImmunologyPathologyDermatologyImmunotherapy
Publications per year
1998–2024
198
198
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Jeffrey S. Weber, Mario Mandalà, Michele Del Vecchio et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
James Larkin, Paolo A. Ascierto, Brigitte Dréno et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · New England Journal of Medicine · 2014 · 1.8K citations · Full text
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà et al. · New England Journal of Medicine · 2018 · 1.8K citations · Full text
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
Georgina V. Long, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text
Rows per page
1–5 of 198